Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 615.97B, Johnson & Johnson(JNJ) trades at $254.50. The stock has a price-to-earnings ratio of 38.52 and currently yields dividends of 2.08%.
As of 2026-10-17, Johnson & Johnson(JNJ) stock has fluctuated between $254.00 and $257.51. The current price stands at $254.50, placing the stock +0.2% above today's low and -1.2% off the high.
The Johnson & Johnson(JNJ)'s current trading volume is 6.55M, compared to an average daily volume of 8.1M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.
JNJ News
Earnings season is underway, and it has already made some winners and losers. One company that seems to be in the latter category is Johnson & Johnson (JNJ +0.9...
Investing Procter & Gamble Has Raised Its Dividend for 70 Years. These 2 Stocks Share Its Advantage Raising dividends through two recessions takes more than a g...
Healthcare remains a cornerstone for long-term investors, but choosing between a pure-play drugmaker and a diversified conglomerate is difficult. Is Bristol-Mye...
Analyst ratings
70%
of 27 ratingsMore JNJ News
On its third quarter of 2026 earnings call, held on Oct. 13, 2026, Johnson & Johnson (JNJ +0.79%) raised its full-year sales outlook after operational revenue g...
This week's dividend activity included increased payouts from Interactive Brokers Group (IBKR) and Citizens Financial Group (CFG) as well as declarations from J...
Johnson & Johnson raised its full year 2026 guidance after reporting higher sales from its Innovative Medicine segment, backed by TREMFYA long term Crohn's dise...
Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Johnson & Johnson (JNJ) to $287 from $275 and keeps an Overweight rating on the shares. Wi...
...
Morgan Stanley lowered the firm’s price target on Johnson & Johnson to $292 from $294 and keeps an Overweight rating on the shares. The company posted “a genera...
Shares of Johnson & Johnson (NYSE:JNJ) rose in early trading on Wednesday, after the company reported upbeat third-quarter results. Here are some key analyst t...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.